Multibagger Insights

Multibagger Insights

Home
Notes
Deep Dives
Lessons
Archive
Leaderboard
About

Deep Dives

Top 5 SaaS Names in Multibagger Watchlist
A moat‑driven, DCF‑backed watchlist of my highest‑conviction SaaS compounders.
 • The T-shaped Investor
Not All SaaS Are Created Equal
Axon’s Q4 2025 Earnings Just Proved It
 • The T-shaped Investor
ServiceNow: My Last Week's Realization
The Day Antigravity Broke — And What It Taught Me About Moats, Vibe Coding, and Why ServiceNow Might Be Your Next 10x
 • The T-shaped Investor
ServiceNow a Falling Knife?
The AI Control Tower Thesis
 • The T-shaped Investor
Omada Health (Part 2): A Between-visit Care for Chronic Conditions
$0 Debt, 55% Active User Growth, 51.5% Revenue growth, Trading at 2.6x Revenue
 • The T-shaped Investor
Omada Health (Part 1): A Between-visit Care for Chronic Conditions
Tailwinds: GLP-1 Care Track and PBM Channel Expansion
 • The T-shaped Investor
Which Software Stock Survives the AI Transition?
ServiceNow vs. Salesforce vs. Adobe vs. GitLab: My Software Stock Pick for 2026
 • The T-shaped Investor
Quick Thoughts On Harrow Inc
VEVYE and IHEEZO Today, Biosimilars and MELT-300 Tomorrow, and My Valuation for 2027.
 • The T-shaped Investor
Why I Remain Bullish about Harrow Inc
Key reasons for my optimism: product development, affordability, and future pipeline.
 • The T-shaped Investor
Zeta Global: Data, Diversification, and Dilemmas
A Balanced Look at Zeta’s Strengths, Valuation, and Lingering Concerns
 • The T-shaped Investor
PROCEPT BioRobotics
A High-Growth Leader in BPH Treatment Facing Headwinds on the Road to Profitability
 • The T-shaped Investor
Harrow Inc: Asymmetric Upside with Real Risks
Scaling branded products, Expanding into Retinal Biosimilars, and Reshaping U.S. Eyecare
 • The T-shaped Investor
© 2026 InsightButter LLC · Publisher Terms
Substack · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture